Show simple item record

dc.contributor.authorD'Jaen, Gabrielaen_US
dc.contributor.authorPantanowitz, Lironen_US
dc.contributor.authorBower, Marken_US
dc.contributor.authorBuskin, Susanen_US
dc.contributor.authorNeil, Nancyen_US
dc.contributor.authorGreco, Erinen_US
dc.contributor.authorCooley, Timothyen_US
dc.contributor.authorHenry, Daviden_US
dc.contributor.authorStem, Jonathanen_US
dc.contributor.authorDezube, Bruceen_US
dc.contributor.authorStebbing, Justinen_US
dc.contributor.authorAboulafia, Daviden_US
dc.date.accessioned2012-01-09T20:56:28Z
dc.date.available2012-01-09T20:56:28Z
dc.date.copyright2010
dc.date.issued2010-10-11
dc.identifier.citationD'Jaen, Gabriela, Liron Pantanowitz, Mark Bower, Susan Buskin, Nancy Neil, Erin Greco, Timothy Cooley, David Henry, Jonathan Stem, Bruce Dezube, Justin Stebbing, David Aboulafia. "HIV-associated primary lung cancer (LC) in the era of highly active antiretroviral therapy (HAART): a multi-institutional collaboration" Infectious Agents and Cancer 5(Suppl 1):A32. (2010)
dc.identifier.issn1750-9378
dc.identifier.urihttps://hdl.handle.net/2144/2917
dc.language.isoen
dc.publisherBioMed Centralen_US
dc.rightsCopyright 2010 D'Jaen et al; licensee BioMed Central Ltd.en_US
dc.titleHIV-Associated Primary Lung Cancer (LC) in the Era of Highly Active Antiretroviral Therapy (HAART): A Multi-Institutional Collaborationen_US
dc.typeArticleen_US
dc.identifier.doi10.1186/1750-9378-5-S1-A32
dc.identifier.pmcid3002691


This item appears in the following Collection(s)

Show simple item record